arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Regeneron Pharmaceuticals, Inc.

REGN Health Care Biotechnology: Pharmaceutical Preparations
$635.45
▲ +1.1% Today
as of Jun 7, 07:25 ET
Last 30 days -13.16% Apr 28 → Jun 05
$590.17 $628.19 $666.21 $704.24 $742.26 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$632.26
High
$640.82
Low
$632.09
Volume
$975,513
Avg Vol
$948,143
Mkt Cap
$65.2B
P/E (TTM)
19.15
Beta
52w High
$821.11
52w Low
$476.49
Div Yield
Shares Out

Overview

52-week range
$476
$821
46% of range
Avg surprise (last 1)
-2.7%
Avg reaction (last 1)
-6.9%
0% positive
Latest IV / EM
42%
EM ±3.9% · $635 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$6.27$8.11$9.95$11.78$13.62 Actual $8.50Actual $8.89Actual $6.27Actual $12.41Actual $11.54Actual $6.43Est $6.61Actual $12.81Actual $13.62Actual $6.75 JunSepMarJunSepMar/2025JunSepMar
Revenue vs Net Income Revenue Net income
$0$383M$766M$1.1B$1.5B Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $6.75 financials
Tue Sep 30, 2025Sep 2025 $13.62 financials
Mon Jun 30, 2025Jun 2025 $12.81 financials
Tue Apr 29, 2025Mar/2025 $6.43 $6.61 -2.7% -6.9% earnings
Mon Sep 30, 2024Sep 2024 $11.54 financials
Sun Jun 30, 2024Jun 2024 $12.41 financials
Sun Mar 31, 2024Mar 2024 $6.27 financials
Sat Sep 30, 2023Sep 2023 $8.89 financials
Fri Jun 30, 2023Jun 2023 $8.50 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$643M$1.03B$1.08B$592M$1.18B$1.07B
Net income$727M$1.46B$1.39B$809M$1.34B$1.43B
EPS (diluted)$6.75$13.62$12.81$7.27$11.54$12.41

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$2.96B$3.12B$2.51B$2.00B$3.09B$2.49B$2.01B$1.92B
Inventory$3.10B$3.20B$3.25B$3.21B$3.19B$3.09B$3.02B$2.87B
Total current assets$18.21B$18.02B$17.98B$16.86B$17.57B$18.66B$19.33B$19.08B
Total assets$40.87B$40.56B$40.17B$38.22B$37.55B$37.76B$37.44B$36.09B
Long-term debt$1.99B$1.99B$1.99B$1.99B$1.98B$1.98B$1.98B$1.98B
Total liabilities$9.45B$9.30B$9.21B$8.28B$8.16B$8.41B$8.12B$7.88B
Total equity$31.42B$31.26B$30.96B$29.94B$29.39B$29.35B$29.33B$28.21B

Implied volatility — last 90 days

37%39%42%44%47% Jun 07 — IV 42% · EM ±3.9%

Sector peers